Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[Supersue]

FROM YAHOO board Acknowledging the "name brand v. generic" comments ... I work with pharma companies all the time, and the combination of two (or more) drugs into a new single dose pill is a very common practice for pharmas. They trademark the brand name, go to market, and sell it exclusively. The outcome won't be based on name brand versus generic arguments, it will ultimately be based on two factors; 1) how good they are at selling this combo pill as a one stop shop to prescribers (aka doctors) and 2) how big the patient pool is for people who need both an anti-inflammatory for osteoarthritis pain and who have hypertension. I'd guess there are a fair amount of elderly people who have both high blood pressure and arthritis, so the determining factor could come down to their success or failure in marketing to prescribers.